AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05347186 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Non biomechanical functional exercises
Description: Conventional treatment involved Non biomechanical Functional exercises (NBF), these exercises indicated for the control group consists of dorsal and plantar flexion of the metatarsophalangeal joints in unloading of the subject in a long sitting position on a chair or couch with the knee at 90◦ for a period of eight weeks. Feet will be in hanging position to allow plantar flexion smoothly. The exercises will carry out daily without any kind of resistance for a period of 30s. A total of five series will be completed for each foot. These exercises will be considered as non-therapeutic which might have affected the foot's posture.
Study NCT05347186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non biomechanical functional exercises
Description: Conventional treatment involved Non biomechanical Functional exercises (NBF), these exercises indicated for the control group consists of dorsal and plantar flexion of the metatarsophalangeal joints in unloading of the subject in a long sitting position on a chair or couch with the knee at 90◦ for a period of eight weeks. Feet will be in hanging position to allow plantar flexion smoothly. The exercises will carry out daily without any kind of resistance for a period of 30s. A total of five series will be completed for each foot. These exercises will be considered as non-therapeutic which might have affected the foot's posture.
Study NCT06243874 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: greater occipital nerve block
Description: greater occipital nerve block
Study NCT06243874 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: transnasal sphenopalatine ganglion block
Description: transnasal sphenopalatine ganglion block
Study NCT05313451 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Soluble fiber
Description: 15g/day during 2 months
Study NCT05313451 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin 15g/day during 2 months
Study NCT06003114 — intervention group
Intervention type: DRUG
Intervention: Palbociclib
Description: Participants taking oral palbociclib as prescribed in first-line treatment.
Study NCT04749823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blended treatment program
Description: A combined treatment program with specific active neck exercises and general aerobic training in counteractive amount will be executed during 12 weeks. Nine supervised sessions will be supplemented with 1 to 3 weekly unsupervised home exercise sessions.
Study NCT04749823 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Specific strength exercise program
Description: This program includes an individual, patient-tailored exercise program with the aim of retraining the neck musculature. A detailed exercise programme will be constructed in which all exercises are listed with the amount of repetitions and series of each exercise. Strength exercises will be performed by means of dumbbells with different weights and elastic bands with different degrees of resistance. The amount of weight or resistance, and the amount of series and repetitions will be evaluated during the first session. This exercise programme will be re-evaluated repeatedly during the course of the program. Specific strength neck exercises will be performed for 30 minutes. Nine supervised sessions will be supplemented with 1 to 3 weekly unsupervised home exercise sessions.
Study NCT04749823 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General aerobic exercise program
Description: This control group will receive a general aerobic exercise program. Within a 12-week period, patients will be instructed to perform a general aerobic exercise session 3 times a week.
Study NCT04816929 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bobath Method
Description: Neurodevelopmental Treatment
Study NCT04816929 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Task-Oriented Approach
Description: Task-Oriented Treatment
Study NCT06246565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10383
Description: HS-10383 administered as one 50 mg, 100 mg 200 mg tablet once daily, depending upon randomization.
Study NCT06246565 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HS-10383 Placebo
Description: HS-10383 administered as one 50 mg, 100 mg 200 mg tablet once daily, depending upon randomization.
Study NCT06466148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JessieHug
Description: Assessment of JessieHug device when placed on infants.
Study NCT04673292 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fixed site standard of care testing
Description: This arm includes all three Johns Hopkins (JHMI) ambulatory outdoor testing sites across Baltimore City. Each site represents a traditional appointment-based scheduling system. Participants will be given a choice of 1 of 3 outdoor testing locations based on their preferences. Study staff will make an appointment for testing based on testing availability and participant schedule.
Study NCT04673292 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-based, mobile van testing
Description: This arm offers the convenience of highly accessible testing and with the flexibility of no fixed appointment time. Each of the 12 geographic strata will have a single, centrally located testing site within the area, providing similar geographic access across households. The testing location will be published on the study website and social media so that participants can visit the location at a time convenient to them.
Study NCT04673292 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-collected, home-based testing
Description: Individuals will receive a home-based testing kit delivered by a courier service as soon as the randomization of the household is complete. The kit will include provisions for contacting the courier service for pick up. Appropriate biohazard precautions are included. Each of the testing components of this kit will include FDA Emergency Use Authorization approved collection methods. Easy to use instructions with options to view pre-recorded videos and/or virtual 'on demand' coaching sessions with members of the study team via a HIPAA-secure Zoom session will be available.
Study NCT04577950 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymphatic drainage of endometrial cancer
Description: Nanocoll® is injected a day before surgery in the cervix at four points. A lymphoscintigraphy is performed 2 or 3 hours afterward. At the beginning of the surgery, the operative field already in place and before the beginning of laparoscopic, 2ml (10mg) of ICG, distributed in four points around the tumor, is injected under the endometrium intra-myometrial under endoscopic control. As ICG spreads slower than blue dye, ICG is always injected first. Then, Bleu Patenté® is injected at two sites in the uterine isthmus, opposite of the uterine arteries. The risk of false negative results, because a tracer migrated too quickly, is reduced when the injection takes place when patients are already anesthetized.
Study NCT06310681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Encompass group programme
Description: * Groups will take place over ten modules~* They will take place in-person at a local community venue~* The groups will be two hours long, with a break for refreshments in the middle. They will take place every fortnight in term-time only over approximately 6 months.~* The groups predominantly follow a participatory learning approach and although the facilitators have manuals, the activities tend to include some imparting of information, key points for discussion, examples from other settings and activities for the group to practice.~* They are run by two facilitators - one parent with lived experience and one healthcare professional
Study NCT05536310 — intervention group
Intervention type: DEVICE
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Description: TAVI with the JenaValve Trilogy Heart Valve System
Study NCT04891068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: 5-Azacitidine is a pyrimidine nucleoside analog in which nitrogen replaces carbon at position 5
Study NCT05587855 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-group
Description: Participants with Hypertension will be assigned to eCulinary medicine
Study NCT05099627 — intervention group
Intervention type: OTHER
Intervention: The questionnaire Cervical myelopathy treatment outcome questionnaire
Description: Information gathered through clinical examination and questionnaires performed retrospectively over the phone, pre-operation and at 3- and 6-months post-operation. The questionnaire Cervical myelopathy treatment outcome questionnaire attached records information relating to co-morbidities and symptomology. The examination will be a thorough neurological examination in addition to a focused cardiovascular examination. Biochemical blood markers from existing blood markers or from GP records, which have been or would have been performed regardless of this trial. Radiological findings will be taken from routine MRI and cervical spine X-rays performed as part of the CSM diagnostic work-up
Study NCT05099627 — intervention group
Intervention type: OTHER
Intervention: The retrospective questionnaire CSM early diagnosis questionnaire
Description: To identify early clinical predictors of cervical myelopathy diagnosis based on individual patient-reported symptoms by using a questionnaire and patient characteristics as well as co-morbities, as well as clinical examination findings provided by community musculoskeletal teams.
Study NCT05099627 — intervention group
Intervention type: OTHER
Intervention: JOACMEQ questionnaire and mJOA
Description: Used for prospective cohort via telephone at 3, 6 and 12-months post-operatively to assess treatment outcomes.
Study NCT06477874 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental implants placement
Description: implants placed in consolidated bone grafts
Study NCT05599542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Solution-oriented approach
Description: A preliminary assessment of the pregnant woman's thoughts on breastfeeding was made and the EARS (Eliciting, Amplifying, Reinforcing and Start Over) process was applied. Eliciting, Amplifying, Reinforcing and Start Over process guides the second and subsequent sessions in a sequential order. The Eliciting, Amplifying, Reinforcing and Start Over technique reminds the counselor of the basic concepts of solution-oriented approach and its explanation is as follows;
Study NCT05599542 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Solution-oriented approach
Description: A preliminary assessment of the pregnant woman's thoughts on breastfeeding was made and the EARS (Eliciting, Amplifying, Reinforcing and Start Over) process was applied. Eliciting, Amplifying, Reinforcing and Start Over process guides the second and subsequent sessions in a sequential order. The Eliciting, Amplifying, Reinforcing and Start Over technique reminds the counselor of the basic concepts of solution-oriented approach and its explanation is as follows;
Study NCT05599542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypno-breastfeeding
Description: A preliminary assessment was made about the pregnant woman's thoughts on breastfeeding. In the hypno-nursing philosophy, affirmation, relaxation, imagination and visualization techniques were used in order to positively affect the subconscious mind during the breastfeeding process.
Study NCT05599542 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hypno-breastfeeding
Description: A preliminary assessment was made about the pregnant woman's thoughts on breastfeeding. In the hypno-nursing philosophy, affirmation, relaxation, imagination and visualization techniques were used in order to positively affect the subconscious mind during the breastfeeding process.
Study NCT06265675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenol
Description: Chemical neurolysis
Study NCT06265675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celestone
Description: Chemical neurolysis with corticosteroid
Study NCT06265675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocain
Description: Chemical neurolysis with local anesthetic
Study NCT06461975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benoxinate Hydrochloride
Description: The first group had the first examination done using the tear substitute Polyfresh ® eye drops and the second using the Benoxinate HCL drops Benox ® given just before the ROP screening.
Study NCT06461975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: artificial tear (Sodium Hyaluronate 2 mg/ml) eye drops.
Description: The second group had the first examination done using the Benoxinate HCL drops Benox ® eye drops and the second using the tear substitute Polyfresh ®given just before the ROP screening.
Study NCT06398548 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Participants continue with their lifestyle as usual, with no modification to lifestyle, or exercise habits.
Study NCT06398548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training
Description: This group cycles at 70% of the resistance associated with their first lactate threshold.
Study NCT06398548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heavy Intensity Continuous Training
Description: This group cycles at 10% of the difference between the resistance associated with their lactate threshold, and maximal achieved watts, added to the resistance associated with their lactate threshold.
Study NCT05241730 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Training intervention
Description: The training intervention will be a 10 week training plan for endurance runners. The plan consists of five sessions per week (three basic endurance sessions and two interval sessions)
Study NCT05241730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training intervention
Description: The training intervention will be a 10 week training plan for endurance runners. The plan consists of five sessions per week (three basic endurance sessions and two interval sessions)
Study NCT05241730 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Glycaemic Index
Description: The subjects eat 55-60 E-% carbohydrates with ≥ 65 % from high glycaemic index carbohydrates per day, the other E-% are fats and proteins.
Study NCT05241730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LCHF
Description: The subjects eat ≥ 65 E-% fats and a maximum of 50 g carbohydrates per day.
Study NCT05241730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Glycaemic Index
Description: The subjects eat 55-60 E-% carbohydrates with ≥ 65 % from low glycaemic index carbohydrates per day, the other E-% are fats and proteins.
Study NCT05644028 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Intervention for ADHD
Description: The intervention will be based on principles from dialectic behavioral therapy. The overall aim of the intervention is to improve emotion regulation skills. The intervention will consist of eight face-to-face group sessions and a digital companion app that the participants can use to practice skills between the sessions. The groups will include mindfulness-based exercises, homework review, introduction to new skills, and peer discussions.
Study NCT05176119 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nalbuphine Injection
Description: At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.
Study NCT05176119 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.
Study NCT05176119 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.
Study NCT04624711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eribulin Mesylate
Description: Eribulin mesylate 1.4mg/m2, administered intravenously on Days 1 and 8 of each 21 day cycle.
Study NCT04624711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib hydrochloride
Description: Anlotinib 12mg, administered orally on Days 1-14 of each 21 day cycle.
Study NCT05085639 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GLS-5130
Description: GLS-5310 DNA plasmid vaccine
Study NCT05085639 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04782271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYL18001 sodium Low dose q.d
Description: 1 drop in the randomized eye once daily
Study NCT04782271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYL18001 sodium Middle dose q.d
Description: 1 drop in the randomized eye once daily
Study NCT04782271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYL18001 sodium High dose q.d
Description: 1 drop in the randomized eye once daily
Study NCT04782271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYL18001 sodium High dose b.i.d
Description: 1 drop in the randomized eye twice daily
Study NCT05959135 — intervention group
Intervention type: DEVICE
Intervention: Gastric ultrasonography
Description: It seems like the text you provided is already in Turkish and it appears to be written in an academic style. If you want this text to be translated to English in an academic language, it would be:~Ultrasonographic evaluation of gastric contents in Diabetic and Non-Diabetic term pregnancies
Study NCT04817644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Description: Oral semaglutide once daily for a total of 10 days
Study NCT05234970 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wysa
Description: Participants in the intervention arm will be able to log into the Wysa app at any time of day. They can chat with the AI-based bot, Wysa, or choose to complete different self-care exercises. These exercises are grouped into tool packs, which include dealing with relationships, overcoming loneliness, managing mood, among many others. Users can engage in simple, therapeutic exercises including mindfulness and cognitive re-structuring for negative thinking.
Study NCT05234970 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Harvard College App
Description: Participants in the control arm will be given instructions on how to download and utilize the Harvard College App. Students assigned to this app receive instructions on how to utilize the app to navigate resources on campus to support their mental health including professional and peer support groups and how to make an appointment at the Counseling and Mental Health Services. Participants cannot send messages or share any information through the app.
Study NCT04933851 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT1VATE
Description: ACT1VATE, informed by Acceptance and Commitment Therapy (ACT), will consist of five, 90-minute group-based telemedicine therapy sessions delivered by a Behavioral Health Provider.
Study NCT04933851 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: DSME/S
Description: Diabetes self-management education and support (DSME/S) will be delivered by a Certified Diabetes Care and Education Specialist via one-on-one telemedicine format.
Study NCT05217745 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MLCT Oil
Description: 1st 12 weeks: frozen ready to eat meals prepared with the oil Last 12 weeks: own diet with provided snacks containing the oil
Study NCT05217745 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: LCT Oil (Corn Oil)
Description: 1st 12 weeks: frozen ready to eat meals prepared with the oil Last 12 weeks: own diet with provided snacks containing the oil
Study NCT05376826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse Led Physical Therapy
Description: Nurse Led Physical Therapy in Form of Range of Motion Exercises
Study NCT04821037 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT
Description: Acceptance and Commitment Therapy
Study NCT06119490 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Abrocitinib
Description: Solu-Medrol® 1 mg/kg body weight intravenous infusion per day in combination with Arocitinib tablets 200 mg per day for 2 weeks
Study NCT06119490 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tofacitinib
Description: Solu-Medrol® 1 mg/kg body weight intravenous infusion per day in combination with Tofacitinib tablets 10 mg per day for 2 weeks
Study NCT05576389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab+Fluzoparib
Description: Fluzoparib：150mg was given orally twice daily Camrelizumab：200 mg IV drip on Day 1 of each cycle
Study NCT06324006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIB-01
Description: LIB-01 oral suspension
Study NCT06324006 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral suspension
Study NCT04035070 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: co-amoxiclav-clindamycin solution
Description: antibiotic-containing solution will be prepared by mixing equal quantities of 1.2gm Co-amoxiclav solution and 600mg Clindamycin solution at a ratio of 1:1 by volume to be used as a root canal irrigating solution